Rockwell Medical names iron-delivery drug Triferic; U. of Nebraska picks up $11.2 grant for nanotech delivery;

@MichaelGFierce: Special report: The race for the artificial pancreas. Report | Follow @MichaelGFierce

> Rockwell Medical now has a name for its investigational iron-delivery drug: Triferic. The FDA accepted the proposed trade name for the previously monickered soluble ferric pyrophosphate. Release

> The University of Nebraska Medical Center has been awarded a grant of more than $11.2 million from the National Institute of General Medical Sciences for its efforts in the areas of drug delivery and nanomedicine. News

> Researchers at The Rockefeller University have developed a new technique by which RNA interference can find genes that cause tumor growth in mice. Report

> Iranian scientists have created multi-layer titania nanotube arrays that can be used in targeted drug delivery. More

> Medgenics ($MEDG) said goodbye to Andrew Pearlman, who retired from his position as CEO, and the company appointed Michael Cola as the new president and chief. Release